Collegium Pharmaceutical

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$205,449
$209,361
$188,000
$177,757
Gross Profit
128,378
129,171
108,384
97,324
EBITDA
303,566
121,709
94,096
80,476
EBIT
133,830
65,203
37,488
23,912
Net Income
16,963
31,507
11,983
2,417
Net Change In Cash
205,449
209,361
188,000
177,757
Free Cash Flow
122,359
78,250
72,374
54,600
Cash
251,102
169,946
117,348
96,192
Basic Shares
39,701
39,439
39,075
32,840

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$780,567
$631,449
$566,767
$463,933
Gross Profit
463,257
377,344
326,169
209,488
EBITDA
401,005
341,702
308,328
173,305
EBIT
174,931
172,542
159,072
34,366
Net Income
62,870
69,190
48,155
-25,002
Net Change In Cash
780,567
631,449
566,767
463,933
Cost of Revenue
-12,738
Free Cash Flow
327,583
203,328
274,288
122,608
Cash
251,102
70,565
238,947
173,688
Basic Shares
39,701
40,424
41,788
33,829

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
$2.04
2025-09-30
$2.25
2025-06-30
$1.68